Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis - PubMed (original) (raw)
Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis
D Baker et al. Cell Immunol. 1991 May.
Abstract
Clinical disease phases of chronic relapsing experimental allergic encephalomyelitis (CREAE) in the Biozzi AB/H mouse model are associated with extensive cellular infiltration of the central nervous system, principally the spinal cord. The activation of these cells is further suggested by the immunocytochemical demonstration of cytokines (migration inhibition factor, interferon-gamma, tumour necrosis factor-alpha, and interleukins 1, 2, and 3) within these infiltrates. The in vitro functions attributed to these cytokines indicate their potential role in cell recruitment, activation, and differentiation of the ongoing immune response which could contribute to the pathogenesis of disease.
Similar articles
- Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M. Hidaka Y, et al. J Neurol Sci. 2014 May 15;340(1-2):117-22. doi: 10.1016/j.jns.2014.02.039. Epub 2014 Mar 11. J Neurol Sci. 2014. PMID: 24655735 - Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice.
Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Baker D, et al. J Neuroimmunol. 1990 Aug;28(3):261-70. doi: 10.1016/0165-5728(90)90019-j. J Neuroimmunol. 1990. PMID: 2373763 - Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
O'Neill JK, Baker D, Turk JL. O'Neill JK, et al. J Neuroimmunol. 1992 Dec;41(2):177-87. doi: 10.1016/0165-5728(92)90068-v. J Neuroimmunol. 1992. PMID: 1469077 - The role of cytokines in experimental autoimmune encephalomyelitis.
Bettelli E, Nicholson LB. Bettelli E, et al. Arch Immunol Ther Exp (Warsz). 2000;48(5):389-98. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140466 Review. - Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis.
Olsson T. Olsson T. Neurology. 1995 Jun;45(6 Suppl 6):S11-5. doi: 10.1212/wnl.45.6_suppl_6.s11. Neurology. 1995. PMID: 7540264 Review.
Cited by
- OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
Sánchez-Fernández A, Skouras DB, Dinarello CA, López-Vales R. Sánchez-Fernández A, et al. Front Immunol. 2019 Nov 1;10:2578. doi: 10.3389/fimmu.2019.02578. eCollection 2019. Front Immunol. 2019. PMID: 31736980 Free PMC article. - Some misconceptions about understanding autoimmunity through experiments with knockouts.
Steinman L. Steinman L. J Exp Med. 1997 Jun 16;185(12):2039-41. doi: 10.1084/jem.185.12.2039. J Exp Med. 1997. PMID: 9221283 Free PMC article. No abstract available. - Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.
Frei K, Eugster HP, Bopst M, Constantinescu CS, Lavi E, Fontana A. Frei K, et al. J Exp Med. 1997 Jun 16;185(12):2177-82. doi: 10.1084/jem.185.12.2177. J Exp Med. 1997. PMID: 9182689 Free PMC article. - IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
Sánchez-Fernández A, Zandee S, Amo-Aparicio J, Charabati M, Prat A, Garlanda C, Eisenmesser EZ, Dinarello CA, López-Vales R. Sánchez-Fernández A, et al. Theranostics. 2021 Jan 1;11(1):1-13. doi: 10.7150/thno.47435. eCollection 2021. Theranostics. 2021. PMID: 33391457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources